Carerx Corporation · TSX:CRRX
Carerx — Q2 2021 Earnings Presentation
15 slides from Carerx's earnings presentation, Aug 10, 2021
Slide 1: Q2 2021 Earnings Call
Slide 2: Forward Looking Statements
Forward Looking Statements Certain of the statements contained in this presentation are "forward looking information within the meaning of applicable Canadian securities legislation. Forward looking information includes, but is not limited to, business strategy, plans and other expectations, beliefs
Slide 3: David Murphy, President & Chief Executive Officer
David Murphy President & Chief Executive Officer
Slide 4: Q2 2021: Continued Execution on our Growth Strategy
Q2 2021: Continued Execution on our Growth Strategy Another quarter of strong growth in revenue and Adjusted EBITDA + Closed two acquisitions and announced largest to date 4
Slide 5: Q2 2021 Financial Highlights
Q2 2021 Financial Highlights From Continuing Operations g©P + Average beds serviced of 53,184: +27% vs Q2/20 * Growth driven primarily by Remedy’s acquisition (Q2/20), as (+/- compared to Q2 2020) ili 2 2021 (millions) Q well as SmartMeds (Q2/21) Revenue $49.7 +25% * Adjusted EBITDA includes quarter
Slide 6: SmartMeds: Another High-Quality Tuck-In Acquisition
SmartMeds: Another High-Quality Tuck-In Closed April 1, 2021 Acquisition » Added 2,400 beds Expected to contribute * Strengthened market position annualized run-rate in Ontario revenue of $13 M and - Excellent reputation as a leader Adjusted EBITDA of $1.5 M in innovation, quality, and before any in
Slide 7: Rexall: Partial Acquisition of a Portion of LTC Pharmacy Business
Rexall: Partial Acquisition of a Portion of LTC Pharmacy Business ¢ Added ~4,000 beds in Ontario & Northern Alberta ¢ Included fulfilment centre in Sudbury Closed June 21, 2021 Expected to contribute annualized run-rate revenue of ~$14M& nominal Adjusted EBITDA prior to any integration synergies 9 d
Slide 8: Medical Pharmacies Acquisition: Our Largest & Most Significant to Date
Medical Pharmacies Acquisition: Our Largest & Most Significant to Date April 19, 2021: Definitive Agreement to Acquire LTC Division of Medical Pharmacies will add ~36,000 beds, serviced through 18 centres in Ontario & Western Canada Further expands Canada’s largest national platform Expected to cont
Slide 9: Andrew Mok, Chief Financial Officer
Andrew Mok Chief Financial Officer
Slide 10: Q2 2020 vs Q2 2021 Results
• • 50 45 40 35 • 30 25 20 15 10 5 0 Q2 2020 Q2 2021
Slide 11: Q2 2021 Financial Results | Adjusted EBITDA
Q2 2021 Financial Results | Adjusted EBITDA Nh Bb $2.8 Q2 2020 (millions) $4.3 Q2 2021 54% year-over-year growth Includes quarterly contribution of >$3.0 Min annualized cost saving synergies Growth driven primarily by Remedy’s acquisition, as well as SmartMeds SmartMeds contribution in line with exp
Slide 12: Balance Sheet
Balance Sheet * Completed a bought private placement (subscription receipts) for gross proceeds of $63.3 M (held in escrow until closing of MPGL transaction) (millions except ratio) * Entered into binding commitment letters with lenders to refinance existing credit facilities: $60 Min new facilities
Slide 13: David Murphy, President & Chief Executive Officer
David Murphy President & Chief Executive Officer
Slide 14: A New Baseline for Continued Growth
. CareR: A New Baseline for ae Continued Growth + Medical a . . Pharmacies Positioned to benefit from increased scale and enhanced capabilities Total Will continue to aggressively pursue organic growth Natural consolidator in a highly fragmented market: Strong pipeline of opportunities Market Opport
Slide 15: Questions
J *.. Questions Visit our website at www.carerx.ca | Follow @CareRx on Twitter $$ CareRx